Abstract:Rationale: Targeting inflammation has been shown to provide clinical benefit in the field of cardiovascular diseases. Although manipulating regulatory T-cell function is an important goal of immunotherapy, the molecules that mediate their suppressive activity remain largely unknown. IL (interleukin)-35, an immunosuppressive cytokine mainly produced by regulatory T cells, is a novel member of the IL-12 family and is composed of an EBI3 (Epstein-Barr virus–induced gene 3) subunit and a p35 subunit. However, the role of IL-35 in infarct healing remains elusive. Objective: This study aimed to determine whether IL-35 signaling is involved in healing and cardiac remodeling after myocardial infarction (MI) and, if so, to elucidate the underlying molecular mechanisms. Methods and Results: IL-35 subunits (EBI3 and p35), which are mainly expressed in regulatory T cells, were upregulated in mice after MI. After IL-35 inhibition, mice showed impaired infarct healing and aggravated cardiac remodeling, as demonstrated by a significant increase in mortality because of cardiac rupture, decreased wall thickness, and worse cardiac function compared with wild-type MI mice. IL-35 inhibition also led to decreased expression of α-SMA (α-smooth muscle actin) and collagen I/III in the hearts of mice after MI. Pharmacological inhibition of IL-35 suppressed the accumulation of Ly6C low and major histocompatibility complex II low /C-C motif chemokine receptor type 2 − (MHC II low CCR2 − ) macrophages in infarcted hearts. IL-35 activated transcription of CX3CR1 (C-X3-C motif chemokine receptor 1) and TGF (transforming growth factor) β1 in macrophages by inducing GP130 signaling, via IL12Rβ2 and phosphorylation of STAT1 (signal transducer and activator of transcription family) and STAT4 and subsequently promoted Ly6C low macrophage survival and extracellular matrix deposition. Moreover, compared with control MI mice, IL-35–treated MI mice showed increased expression of α-SMA and collagen within scars, correlating with decreased left ventricular rupture rates. Conclusions: IL-35 reduces cardiac rupture, improves wound healing, and attenuates cardiac remodeling after MI by promoting reparative CX3CR1 + Ly6C low macrophage survival.

IL-33 Promotes Staphylococcus Aureus-Infected Wound Healing in Mice.

IL-33 Accelerates Cutaneous Wound Healing Involved in Upregulation of Alternatively Activated Macrophages.

Interleukin-33 Increases Antibacterial Defense by Activation of Inducible Nitric Oxide Synthase in Skin.

Interleukin-33 Facilitates Neutrophil Recruitment and Bacterial Clearance in S. Aureus-Caused Peritonitis.

Interleukin-33 Facilitates Neutrophil Recruitment And Bacterial Clearance In S-Aureus-Caused Peritonitis

IL-33 Improves Wound Healing Through Enhanced M2 Macrophage Polarization in Diabetic Mice.

Interleukin-33 Facilitates Cutaneous Defense Against Staphylococcus Aureus by Promoting the Development of Neutrophil Extracellular Trap.

The Role of IL-33 on LPS-Induced Acute Lung Injury in Mice

Interleukin‐33 Deficiency Protects the Skin From Ulcer Formation in an Ischemia–Reperfusion‐Induced Decubitus Mouse Model

Recombinant Expression of Human IL-33 Protein and Its Effect on Skin Wound Healing in Diabetic Mice

Interleukin-35 Promotes Macrophage Survival and Improves Wound Healing after Myocardial Infarction in Mice.

IL-17 and IL-22 Are Pivotal Cytokines to Delay Wound Healing of S. Aureus and P. Aeruginosa Infected Skin.

IL-33-Dependent Group 2 Innate Lymphoid Cells Promote Cutaneous Wound Healing

Interleukin-33 Promotes REG3γ Expression in Intestinal Epithelial Cells and Regulates Gut Microbiota

Interleukin-33 in tumorigenesis, tumor immune evasion, and cancer immunotherapy

IL-36γ Induced by the TLR3-SLUG-VDR Axis Promotes Wound Healing Via REG3A.

Neutralisation of the Interleukin-33/St2 Pathway Ameliorates Experimental Colitis Through Enhancement of Mucosal Healing in Mice.

IL-33 Signaling in Lung Injury.

A Molecular Link Between Interleukin 22 and Intestinal Mucosal Wound Healing.

IL-33 Exerts Neuroprotective Effect in Mice Intracerebral Hemorrhage Model Through Suppressing Inflammation/Apoptotic/Autophagic Pathway

Extended Characterization of IL-33/ST2 As a Predictor for Wound Age Determination in Skin Wound Tissue Samples of Humans and Mice